(MedPage Today) — More good news for GLP-1 agonists, as patients with operable lung cancer and a history of exposure to the drugs had better recurrence-free survival. (Roswell Park Comprehensive Cancer Center)
Artificial intelligence tops the…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/117439
Author :
Publish date : 2025-09-12 16:21:00
Copyright for syndicated content belongs to the linked Source.